Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Sarcoplasmic reticulum calcium-transporting ATPase (SERCA)** is an ATP-dependent membrane pump found in the sarcoplasmic reticulum (SR) of muscle cells and the endoplasmic reticulum (ER) of other cells. It maintains low cytosolic calcium levels by actively transporting calcium ions from the cytosol into the SR, which is essential for muscle relaxation after contraction and for a wide array of cellular processes dependent on intracellular calcium signaling. SERCA is regulated by small transmembrane peptides, such as phospholamban and sarcolipin, as well as recently described micropeptides. Dysregulation of SERCA activity is implicated in diseases including heart failure, muscular disorders, and neurodegenerative conditions, making it an important therapeutic target[1][3][5][8].
Inhibition or modulation of SERCA activity alters calcium uptake into the sarcoplasmic reticulum, thereby affecting cytosolic calcium levels, muscle contraction, and cellular signaling[3][8].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcoplasmic reticulum calcium-transporting ATPase (SERCA).